Innovation for Health - 13 February 2020
Contact Global Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Tim Knotnerus

CEO, AgomAb Therapeutics

 

AgomAb Therapeutics is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues. In April 2019, a 21 million euros financing round was raised. Prior to AgomAb Therapeutics, Tim was VP Corporate Development at AM-Pharma where he was responsible for Corporate and Business Development of the company. In that capacity he co-led the $600M option-to-acquisition deal between Pfizer and AM-Pharma. Prior to that, Tim was a senior associate at Aescap Venture, a venture capital fund investing in European medical companies, where he was instrumental in the financing and support of various portfolio companies. Tim holds an executive MBA from IMD (Switzerland), where he was named Valedictorian, and gained a Science and Innovation Masters and a Drug Innovation Masters, both with honors from Utrecht University (NL).
Marcel Levi
University College London Hospitals
Jan van de Winkel
Genmab
Annemarie Jorritsma
NVP
Ton Rijnders
Lygature
Koen Kas
UGhent & HealthSkouts
Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

Claudia Rijcken
pharmi

Inge Huitinga
Netherlands Brain Bank
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Els Beirnaert
Aelin Therapeutics
Joep Muijrers
PureTech Health
Koenraad Wiedhaup
McKinsey & Company
Esther Talboom-Kamp
Saltro Diagnostics
Elise Meijer
Antwerp Management School & Accenture Strategy
Carine van den Brink
Axon Lawyers
Tim Knotnerus
AgomAb Therapeutics
Sjaak Vink
TheSocialMedwork
Hans Schikan
Topsector Life Sciences & Health
Thijn Brummelkamp
Scenic Biotech
Nadine Rouleaux
Maastricht University
Charlotte Kluit
MSD
Dharminder Chahal
SkylineDx, Van Herk Investments, Swanbridge

Marianne van der Steen
RegMedXB & Maastricht University

Jan de Kerpel
Kempen & Co
Wim Van Hecke
icoMetrix
Wiesje van der Flier 
Alzheimercentrum Amsterdam
Niels Prins
Marco Blom
Alzheimer Nederland
Edwin Moses
Achilles Therapeutics & Evox Therapeutics
Carl Moons
Health Innovation Initiative Holland
Jan Kimpen
Philips
Linda van de Burgwal 
Vrije Universiteit Amsterdam
Onno van de Stolpe
Galapagos
Ton van der Steen
Erasmus MC, Medical Delta & STW
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.